| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | disaccharide binding | 2.80e-07 | 7 | 41 | 3 | GO:0048030 | |
| GeneOntologyMolecularFunction | galactoside binding | 6.69e-07 | 9 | 41 | 3 | GO:0016936 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 8.94e-06 | 20 | 41 | 3 | GO:0070492 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 5.49e-04 | 78 | 41 | 3 | GO:0043539 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 2.70e-08 | 4 | 40 | 3 | GO:0043322 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell proliferation | 4.60e-08 | 19 | 40 | 4 | GO:0046642 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell degranulation | 3.76e-07 | 8 | 40 | 3 | GO:0043321 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 3.02e-06 | 15 | 40 | 3 | GO:0032815 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell proliferation | 3.02e-06 | 15 | 40 | 3 | GO:2000562 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell activation | 3.07e-06 | 52 | 40 | 4 | GO:0046636 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell proliferation | 3.31e-06 | 53 | 40 | 4 | GO:0046640 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 4.51e-06 | 17 | 40 | 3 | GO:0043301 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell proliferation | 5.11e-06 | 59 | 40 | 4 | GO:0046633 | |
| GeneOntologyBiologicalProcess | natural killer cell degranulation | 5.40e-06 | 18 | 40 | 3 | GO:0043320 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response to bacterium | 6.41e-06 | 19 | 40 | 3 | GO:1900426 | |
| GeneOntologyBiologicalProcess | regulation of T cell chemotaxis | 7.53e-06 | 20 | 40 | 3 | GO:0010819 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 8.77e-06 | 21 | 40 | 3 | GO:0032823 | |
| GeneOntologyBiologicalProcess | regulation of defense response to bacterium | 1.70e-05 | 26 | 40 | 3 | GO:1900424 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell proliferation | 2.14e-05 | 28 | 40 | 3 | GO:2000561 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell proliferation | 2.65e-05 | 30 | 40 | 3 | GO:0035739 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte chemotaxis | 2.92e-05 | 31 | 40 | 3 | GO:1901623 | |
| GeneOntologyBiologicalProcess | positive regulation of regulatory T cell differentiation | 2.92e-05 | 31 | 40 | 3 | GO:0045591 | |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 3.22e-05 | 32 | 40 | 3 | GO:1903306 | |
| GeneOntologyBiologicalProcess | T cell chemotaxis | 3.54e-05 | 33 | 40 | 3 | GO:0010818 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation in thymus | 5.02e-05 | 37 | 40 | 3 | GO:0033081 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 5.42e-05 | 107 | 40 | 4 | GO:0042130 | |
| GeneOntologyBiologicalProcess | natural killer cell differentiation | 5.44e-05 | 38 | 40 | 3 | GO:0001779 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 6.35e-05 | 40 | 40 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell activation | 6.35e-05 | 40 | 40 | 3 | GO:2000515 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell migration | 6.84e-05 | 41 | 40 | 3 | GO:2000406 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 6.84e-05 | 41 | 40 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 7.36e-05 | 42 | 40 | 3 | GO:0002323 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage activation | 7.36e-05 | 42 | 40 | 3 | GO:0043032 | |
| GeneOntologyBiologicalProcess | positive regulation of SMAD protein signal transduction | 7.90e-05 | 43 | 40 | 3 | GO:0060391 | |
| GeneOntologyBiologicalProcess | negative regulation of exocytosis | 9.06e-05 | 45 | 40 | 3 | GO:0045920 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 9.62e-05 | 124 | 40 | 4 | GO:0050672 | |
| GeneOntologyBiologicalProcess | positive regulation of oxidoreductase activity | 9.68e-05 | 46 | 40 | 3 | GO:0051353 | |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | 1.02e-04 | 126 | 40 | 4 | GO:0032945 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 1.03e-04 | 47 | 40 | 3 | GO:0001911 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 type immune response | 1.03e-04 | 47 | 40 | 3 | GO:2000316 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-10 production | 1.10e-04 | 48 | 40 | 3 | GO:0032733 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte migration | 1.17e-04 | 49 | 40 | 3 | GO:2000403 | |
| GeneOntologyBiologicalProcess | regulation of regulatory T cell differentiation | 1.17e-04 | 49 | 40 | 3 | GO:0045589 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte proliferation | 1.30e-04 | 134 | 40 | 4 | GO:0070664 | |
| GeneOntologyBiologicalProcess | negative regulation of type II interferon production | 1.32e-04 | 51 | 40 | 3 | GO:0032689 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 1.40e-04 | 52 | 40 | 3 | GO:0031342 | |
| GeneOntologyBiologicalProcess | lymphocyte chemotaxis | 1.48e-04 | 53 | 40 | 3 | GO:0048247 | |
| GeneOntologyBiologicalProcess | macrophage activation | 1.54e-04 | 140 | 40 | 4 | GO:0042116 | |
| GeneOntologyBiologicalProcess | regulatory T cell differentiation | 1.56e-04 | 54 | 40 | 3 | GO:0045066 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell activation | 1.58e-04 | 141 | 40 | 4 | GO:0046634 | |
| GeneOntologyBiologicalProcess | regulation of T cell migration | 1.74e-04 | 56 | 40 | 3 | GO:2000404 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell activation | 2.25e-04 | 61 | 40 | 3 | GO:0032814 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte degranulation | 2.48e-04 | 63 | 40 | 3 | GO:0043300 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 2.48e-04 | 63 | 40 | 3 | GO:0007157 | |
| GeneOntologyBiologicalProcess | T-helper 17 type immune response | 2.59e-04 | 64 | 40 | 3 | GO:0072538 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell activation | 3.30e-04 | 171 | 40 | 4 | GO:0050868 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-10 production | 3.98e-04 | 74 | 40 | 3 | GO:0032653 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 4.31e-04 | 76 | 40 | 3 | GO:0042269 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte migration | 4.47e-04 | 77 | 40 | 3 | GO:2000401 | |
| GeneOntologyBiologicalProcess | interleukin-10 production | 4.47e-04 | 77 | 40 | 3 | GO:0032613 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 5.01e-04 | 80 | 40 | 3 | GO:0002715 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte cell-cell adhesion | 5.12e-04 | 192 | 40 | 4 | GO:1903038 | |
| GeneOntologyBiologicalProcess | T cell migration | 5.19e-04 | 81 | 40 | 3 | GO:0072678 | |
| GeneOntologyBiologicalProcess | regulation of macrophage activation | 5.19e-04 | 81 | 40 | 3 | GO:0043030 | |
| GeneOntologyBiologicalProcess | receptor clustering | 5.58e-04 | 83 | 40 | 3 | GO:0043113 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 5.58e-04 | 83 | 40 | 3 | GO:0002707 | |
| GeneOntologyBiologicalProcess | positive regulation of chemokine production | 5.77e-04 | 84 | 40 | 3 | GO:0032722 | |
| GeneOntologyBiologicalProcess | regulation of oxidoreductase activity | 5.77e-04 | 84 | 40 | 3 | GO:0051341 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-1 production | 6.61e-04 | 88 | 40 | 3 | GO:0032732 | |
| GeneOntologyBiologicalProcess | regulation of SMAD protein signal transduction | 7.06e-04 | 90 | 40 | 3 | GO:0060390 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 7.06e-04 | 90 | 40 | 3 | GO:0098586 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte activation | 7.29e-04 | 211 | 40 | 4 | GO:0051250 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 8.52e-04 | 96 | 40 | 3 | GO:0002704 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 9.41e-04 | 226 | 40 | 4 | GO:0045580 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell activation | 9.57e-04 | 227 | 40 | 4 | GO:0046631 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell activation | 9.59e-04 | 100 | 40 | 3 | GO:2000514 | |
| GeneOntologyBiologicalProcess | positive regulation of mononuclear cell migration | 1.07e-03 | 104 | 40 | 3 | GO:0071677 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 1.10e-03 | 105 | 40 | 3 | GO:0042267 | |
| GeneOntologyBiologicalProcess | regulation of T cell proliferation | 1.11e-03 | 236 | 40 | 4 | GO:0042129 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion | 1.16e-03 | 239 | 40 | 4 | GO:0051048 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte activation | 1.18e-03 | 240 | 40 | 4 | GO:0002695 | |
| GeneOntologyBiologicalProcess | leukocyte degranulation | 1.20e-03 | 108 | 40 | 3 | GO:0043299 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 1.23e-03 | 109 | 40 | 3 | GO:0002228 | |
| GeneOntologyBiologicalProcess | SMAD protein signal transduction | 1.26e-03 | 110 | 40 | 3 | GO:0060395 | |
| GeneOntologyBiologicalProcess | maintenance of protein location | 1.33e-03 | 112 | 40 | 3 | GO:0045185 | |
| GeneOntologyBiologicalProcess | female pregnancy | 1.35e-03 | 249 | 40 | 4 | GO:0007565 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 1.40e-03 | 114 | 40 | 3 | GO:0045824 | |
| GeneOntologyBiologicalProcess | T cell differentiation in thymus | 1.40e-03 | 114 | 40 | 3 | GO:0033077 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion | 1.41e-03 | 252 | 40 | 4 | GO:0022408 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.44e-03 | 115 | 40 | 3 | GO:0090100 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA replication | 1.44e-03 | 29 | 40 | 2 | GO:0008156 | |
| GeneOntologyBiologicalProcess | lymphocyte migration | 1.47e-03 | 116 | 40 | 3 | GO:0072676 | |
| GeneOntologyBiologicalProcess | negative regulation of cell activation | 1.67e-03 | 264 | 40 | 4 | GO:0050866 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-6 production | 1.70e-03 | 122 | 40 | 3 | GO:0032755 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 1.72e-03 | 266 | 40 | 4 | GO:0045619 | |
| GeneOntologyBiologicalProcess | natural killer cell activation | 1.78e-03 | 124 | 40 | 3 | GO:0030101 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 1.78e-03 | 124 | 40 | 3 | GO:0001910 | |
| GeneOntologyBiologicalProcess | regulation of chemokine production | 1.82e-03 | 125 | 40 | 3 | GO:0032642 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor production | 2.18e-03 | 133 | 40 | 3 | GO:0032760 | |
| GeneOntologyBiologicalProcess | chemokine production | 2.27e-03 | 135 | 40 | 3 | GO:0032602 | |
| GeneOntologyBiologicalProcess | T cell proliferation | 2.29e-03 | 288 | 40 | 4 | GO:0042098 | |
| MousePheno | enhanced humoral immune response | 5.94e-06 | 17 | 30 | 3 | MP:0020155 | |
| MousePheno | increased T-helper 1 cell number | 8.44e-06 | 19 | 30 | 3 | MP:0008086 | |
| MousePheno | increased spleen germinal center size | 1.53e-05 | 23 | 30 | 3 | MP:0008483 | |
| MousePheno | abnormal lymph node germinal center morphology | 1.53e-05 | 23 | 30 | 3 | MP:0008522 | |
| MousePheno | abnormal T-helper 1 cell number | 1.75e-05 | 24 | 30 | 3 | MP:0008085 | |
| MousePheno | abnormal lymph node secondary follicle morphology | 1.99e-05 | 25 | 30 | 3 | MP:0002346 | |
| MousePheno | lymph node hyperplasia | 4.66e-05 | 33 | 30 | 3 | MP:0008102 | |
| MousePheno | thymus hyperplasia | 5.10e-05 | 34 | 30 | 3 | MP:0000708 | |
| MousePheno | increased susceptibility to induced arthritis | 6.07e-05 | 36 | 30 | 3 | MP:0003724 | |
| MousePheno | abnormal lymph node B cell domain morphology | 1.11e-04 | 44 | 30 | 3 | MP:0002344 | |
| MousePheno | abnormal T-helper 1 cell morphology | 1.45e-04 | 48 | 30 | 3 | MP:0002433 | |
| MousePheno | abnormal lymph node cortex morphology | 1.63e-04 | 50 | 30 | 3 | MP:0002343 | |
| MousePheno | increased T-helper cell number | 2.29e-04 | 56 | 30 | 3 | MP:0013763 | |
| MousePheno | abnormal skeleton physiology | 3.06e-04 | 632 | 30 | 7 | MP:0001533 | |
| MousePheno | decreased regulatory T cell number | 3.40e-04 | 64 | 30 | 3 | MP:0004974 | |
| MousePheno | increased B cell proliferation | 5.43e-04 | 75 | 30 | 3 | MP:0005154 | |
| MousePheno | abnormal neutrophil cell number | 5.74e-04 | 499 | 30 | 6 | MP:0012440 | |
| MousePheno | abnormal kidney size | 6.39e-04 | 714 | 30 | 7 | MP:0002706 | |
| MousePheno | abnormal neutrophil morphology | 6.51e-04 | 511 | 30 | 6 | MP:0005065 | |
| MousePheno | abnormal Peyer's patch morphology | 7.30e-04 | 83 | 30 | 3 | MP:0000696 | |
| MousePheno | abnormal gut-associated lymphoid tissue morphology | 7.82e-04 | 85 | 30 | 3 | MP:0002378 | |
| MousePheno | spleen hyperplasia | 7.82e-04 | 85 | 30 | 3 | MP:0000693 | |
| Domain | Gal-bind_lectin | 3.76e-06 | 15 | 39 | 3 | SM00908 | |
| Domain | GALECTIN | 3.76e-06 | 15 | 39 | 3 | PS51304 | |
| Domain | Galectin_CRD | 3.76e-06 | 15 | 39 | 3 | IPR001079 | |
| Domain | Gal-bind_lectin | 3.76e-06 | 15 | 39 | 3 | PF00337 | |
| Domain | GLECT | 3.76e-06 | 15 | 39 | 3 | SM00276 | |
| Domain | - | 1.02e-03 | 95 | 39 | 3 | 2.60.120.200 | |
| Domain | ConA-like_dom | 1.10e-03 | 219 | 39 | 4 | IPR013320 | |
| Domain | SET_dom | 4.89e-03 | 50 | 39 | 2 | IPR001214 | |
| Domain | SET | 4.89e-03 | 50 | 39 | 2 | PS50280 | |
| Domain | zf-RING_2 | 5.27e-03 | 52 | 39 | 2 | PF13639 | |
| Pubmed | 1.16e-10 | 8 | 41 | 4 | 31661141 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 16990264 | ||
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 1.52e-09 | 3 | 41 | 3 | 29458010 | |
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 18005988 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 23585851 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 24477688 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 19776007 | ||
| Pubmed | A unique role for galectin-9 in angiogenesis and inflammatory arthritis. | 1.52e-09 | 3 | 41 | 3 | 29433546 | |
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 26582205 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 37105392 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 9153289 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 33316546 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 18974023 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 9038233 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 23144904 | ||
| Pubmed | Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | 1.52e-09 | 3 | 41 | 3 | 29651447 | |
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 36479526 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 28704475 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 21146220 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 23242525 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 1.52e-09 | 3 | 41 | 3 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 1.52e-09 | 3 | 41 | 3 | 33923930 | |
| Pubmed | Alarmin function of galectin-9 in murine respiratory tularemia. | 1.52e-09 | 3 | 41 | 3 | 25898318 | |
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 31937306 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 21426359 | ||
| Pubmed | Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. | 1.52e-09 | 3 | 41 | 3 | 31969388 | |
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 23836896 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 18282810 | ||
| Pubmed | Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. | 1.52e-09 | 3 | 41 | 3 | 35241678 | |
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 1.52e-09 | 3 | 41 | 3 | 7890611 | |
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 1.52e-09 | 3 | 41 | 3 | 22341088 | |
| Pubmed | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | 1.52e-09 | 3 | 41 | 3 | 28990062 | |
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 32380082 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 24083426 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 23667648 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 37279535 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 18579572 | ||
| Pubmed | The protective function of galectin-9 in liver ischemia and reperfusion injury in mice. | 1.52e-09 | 3 | 41 | 3 | 25931247 | |
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 22627368 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 28877989 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 33153471 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 19800850 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 22052881 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 17560833 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 38987795 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 35643073 | ||
| Pubmed | Galectin-9 functionally impairs natural killer cells in humans and mice. | 1.52e-09 | 3 | 41 | 3 | 23408620 | |
| Pubmed | Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. | 6.08e-09 | 4 | 41 | 3 | 20463811 | |
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 38686388 | ||
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 22677125 | ||
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 32855403 | ||
| Pubmed | Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain. | 6.08e-09 | 4 | 41 | 3 | 23657851 | |
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 19234217 | ||
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 18826117 | ||
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 24333756 | ||
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 38853593 | ||
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 35715604 | ||
| Pubmed | Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. | 6.08e-09 | 4 | 41 | 3 | 24958847 | |
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 19017954 | ||
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 30120235 | ||
| Pubmed | Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation. | 6.08e-09 | 4 | 41 | 3 | 33963043 | |
| Pubmed | Galectin-9: A novel promoter of atherosclerosis progression. | 6.08e-09 | 4 | 41 | 3 | 36459823 | |
| Pubmed | [Expression of Galectin-9 and Tim-3 in lungs of mice with asthma]. | 6.08e-09 | 4 | 41 | 3 | 21575348 | |
| Pubmed | Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. | 6.08e-09 | 4 | 41 | 3 | 18346632 | |
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 11839756 | ||
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 33107565 | ||
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 19670381 | ||
| Pubmed | Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. | 6.08e-09 | 4 | 41 | 3 | 29611821 | |
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 30763585 | ||
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 25450716 | ||
| Pubmed | The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. | 6.08e-09 | 4 | 41 | 3 | 16286920 | |
| Pubmed | Galectin-9 regulates the threshold of B cell activation and autoimmunity. | 6.08e-09 | 4 | 41 | 3 | 34369876 | |
| Pubmed | Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2. | 6.08e-09 | 4 | 41 | 3 | 33727589 | |
| Pubmed | Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. | 6.08e-09 | 4 | 41 | 3 | 19362679 | |
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 33203936 | ||
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 25578313 | ||
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 29844236 | ||
| Pubmed | Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. | 6.08e-09 | 4 | 41 | 3 | 22021615 | |
| Pubmed | Embryonic implantation in galectin 1/galectin 3 double mutant mice. | 1.52e-08 | 5 | 41 | 3 | 9566950 | |
| Pubmed | 1.52e-08 | 5 | 41 | 3 | 29242193 | ||
| Pubmed | 1.52e-08 | 5 | 41 | 3 | 28951537 | ||
| Pubmed | 1.52e-08 | 5 | 41 | 3 | 26278059 | ||
| Pubmed | Galectin-9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin-dependent manner. | 1.52e-08 | 5 | 41 | 3 | 34847625 | |
| Pubmed | 1.52e-08 | 5 | 41 | 3 | 22469568 | ||
| Pubmed | 1.52e-08 | 5 | 41 | 3 | 37352334 | ||
| Pubmed | 1.52e-08 | 5 | 41 | 3 | 33664349 | ||
| Pubmed | The glucose transporter 2 regulates CD8+ T cell function via environment sensing. | 1.52e-08 | 5 | 41 | 3 | 37884694 | |
| Pubmed | 1.52e-08 | 5 | 41 | 3 | 25158758 | ||
| Pubmed | 1.52e-08 | 5 | 41 | 3 | 21385853 | ||
| Pubmed | C/EBPzeta (CHOP/Gadd153) is a negative regulator of LPS-induced IL-6 expression in B cells. | 1.52e-08 | 5 | 41 | 3 | 19782405 | |
| Pubmed | Tim3 binding to galectin-9 stimulates antimicrobial immunity. | 3.03e-08 | 6 | 41 | 3 | 20937702 | |
| Pubmed | 3.03e-08 | 6 | 41 | 3 | 8674632 | ||
| Pubmed | 3.03e-08 | 6 | 41 | 3 | 28394331 | ||
| Pubmed | 3.03e-08 | 6 | 41 | 3 | 23296703 | ||
| Pubmed | Role of galectin-1 in the developing mouse olfactory system. | 5.30e-08 | 7 | 41 | 3 | 8873770 | |
| Pubmed | 8.48e-08 | 8 | 41 | 3 | 23751344 | ||
| Pubmed | 8.48e-08 | 8 | 41 | 3 | 36883358 | ||
| Pubmed | 1.27e-07 | 9 | 41 | 3 | 21670307 | ||
| Pubmed | Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells. | 1.27e-07 | 9 | 41 | 3 | 25065622 | |
| Pubmed | 3.32e-07 | 12 | 41 | 3 | 23817958 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q36 | 3.95e-04 | 159 | 41 | 3 | chr7q36 | |
| Cytoband | 7q11.23 | 3.43e-03 | 97 | 41 | 2 | 7q11.23 | |
| Cytoband | 19q13.33 | 4.08e-03 | 106 | 41 | 2 | 19q13.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 5.49e-03 | 797 | 41 | 4 | chr19p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q24 | 6.62e-03 | 136 | 41 | 2 | chr16q24 | |
| GeneFamily | Galectins | 9.25e-07 | 15 | 24 | 3 | 629 | |
| GeneFamily | Ring finger proteins | 5.56e-03 | 275 | 24 | 3 | 58 | |
| Coexpression | MORI_MATURE_B_LYMPHOCYTE_DN | 8.66e-06 | 83 | 41 | 4 | MM596 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_DN | 1.47e-05 | 200 | 41 | 5 | M8842 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.35e-07 | 194 | 41 | 5 | 1a188e52f2f0b6eca3e8d4a4671d9beab0fbbb88 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.59e-07 | 195 | 41 | 5 | 3365768101454060b9ea96ef6b426c76c150bc8f | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-06 | 197 | 41 | 5 | d624f3a105b19f19a0dd253ce8de3ed13adc1f01 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-05 | 166 | 41 | 4 | eb9c81fa7573de7aff6670e7dad313f02129809f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 177 | 41 | 4 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 183 | 41 | 4 | d26c7b79895de28961b8d68351f28d4bb531c75c | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.38e-05 | 183 | 41 | 4 | 49f3ddc1c7c04b4ca837dbd6dad995add82941d6 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.00e-05 | 194 | 41 | 4 | 49cc5f5de4380302100e8cd937f08abe317ac75e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.00e-05 | 194 | 41 | 4 | fb935df966c451e659b8bde281f8aebcb632f6cf | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-NK-Cycling_NK|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.00e-05 | 194 | 41 | 4 | af08047e5728ee8198d2686af6a774f2acfa58ba | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-05 | 195 | 41 | 4 | c5f33b420c9ac14dc67fea632b8c2bc2442cbf3d | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-05 | 195 | 41 | 4 | 219c5d0cde7f6082755154f54db221413ec555cb | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-goblet|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-05 | 196 | 41 | 4 | c2d17630f7bfc9e727de55e093c17fddac61b61f | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.12e-05 | 196 | 41 | 4 | 614a07334707eafe238d5cb7b080a3ca796a1920 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-05 | 196 | 41 | 4 | 847b3377f463bfded046eec63cc1b547f3dc33c1 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-goblet-Goblet_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-05 | 196 | 41 | 4 | 54c30023d04e7265373647f56fc93885804938b0 | |
| ToppCell | Transverse-T_cell-cycling_gd_T|Transverse / Region, Cell class and subclass | 3.24e-05 | 198 | 41 | 4 | 5131b0b7d6c4dd8872cef9f2e233f59f751b4690 | |
| ToppCell | Transverse-(1)_T_cell-(18)_cycling_gd_T|Transverse / shred on region, Cell_type, and subtype | 3.24e-05 | 198 | 41 | 4 | 396dddf7ebad41c3a91329b6a280623c0dfdcd2f | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.01e-05 | 72 | 41 | 3 | 7877184d5c9dd6d96476d71e7504e58c0b4d0f26 | |
| Disease | interleukin 2 receptor antagonist measurement | 9.35e-04 | 35 | 38 | 2 | EFO_0008332 | |
| Disease | mean arterial pressure | 3.78e-03 | 499 | 38 | 4 | EFO_0006340 | |
| Disease | Liver carcinoma | 4.00e-03 | 507 | 38 | 4 | C2239176 | |
| Disease | axial length measurement | 4.45e-03 | 77 | 38 | 2 | EFO_0005318 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RKTPQGPGRKPRRRP | 96 | P04920 | |
| ARRRPGPPRIAPPKL | 11 | Q9H211 | |
| RRSPPGRPRPEPRNA | 136 | O94850 | |
| PPLPAAPGPRRRRRP | 51 | Q8TE56 | |
| APGPRRRRRPRTPPA | 56 | Q8TE56 | |
| GPPAPSKPRRGRRPK | 1261 | Q29RF7 | |
| SRGPRRDPPRRPPRN | 11 | Q5T089 | |
| MRRPRGEPGPRAPRP | 1 | Q14296 | |
| LPRAPRGRRRPNPPR | 361 | Q9NYG8 | |
| RGRRRPNPPRKPVRP | 366 | Q9NYG8 | |
| PNPPRKPVRPRGPGR | 371 | Q9NYG8 | |
| PPRPRGRRQKPPSVR | 171 | Q6DKI2 | |
| PPRPRGRRQKPPSVR | 171 | Q3B8N2 | |
| PPRPRGRRQKPPGVW | 171 | O00182 | |
| PPKRPGGRRRGRLPN | 346 | Q15910 | |
| PGASPGVRRRRPPRP | 61 | A0PJZ3 | |
| GVRRRRPPRPRPRAG | 66 | A0PJZ3 | |
| RPPRPRPRAGRRGAA | 71 | A0PJZ3 | |
| RGRRRRRRPMSPPPP | 6 | Q9UM47 | |
| PPPRPRTGRAPRGRR | 11 | Q2PZI1 | |
| APRRPRRPRRPGPSD | 341 | Q969F8 | |
| KPPRPPRPLRKGRVR | 501 | Q8IXW0 | |
| KRRFGPGRRPGRPPK | 396 | Q9NQV6 | |
| RNRPGRRPPARPAPR | 146 | A8CG34 | |
| GPGPARPARARPRRP | 131 | P53539 | |
| RMRRPPGGGRPQPRL | 81 | Q9NQX5 | |
| RMRGGAPPRERPKPR | 201 | Q6ZN01 | |
| RRRGPRRPQKPIPPA | 551 | Q53TQ3 | |
| RARPPPRRRPGPRWP | 26 | Q8TAE8 | |
| RPRRRGPTRPTPPGA | 156 | Q9H987 | |
| SPRPRRRLGPPPAGR | 716 | P84550 | |
| RGRRRPRPAPPRGSS | 406 | A6NNA2 | |
| QPRDPVRPPRRGRGP | 76 | Q96DX4 | |
| PTGRPRGRPEGRRNP | 101 | Q9H5J8 | |
| KAKRDGPPRPRGRPR | 1161 | Q9ULL5 | |
| GPPRPRGRPRIRPLE | 1166 | Q9ULL5 | |
| PPPPRSRGRPRFLRG | 96 | O75526 | |
| GRARRPPGKPNPRRP | 836 | O95985 | |
| RPGHRPPGRPRRCPK | 36 | Q8WWF5 | |
| RRPPPERTRRGRGAP | 771 | Q5VUG0 | |
| DRPKPRRRPRPREGG | 2376 | Q9H254 | |
| PPGRPQPDSGRRRRR | 6 | P51991 | |
| LGERPPPRPRRPRTQ | 986 | Q96JG9 | |
| RRPPPRPPCRLSMGR | 1021 | Q8N398 | |
| RRPRGLRCSRLPPPP | 21 | Q9ULT6 | |
| AGQPRLGPPPRRARR | 31 | Q96J92 | |
| RPPRAPLRGPRAPPR | 276 | Q66K66 |